Dean S. Elterman, MD

MD, MSc, FRCSC
University of Toronto

Dr. Dean Elterman, MD, MSc, FRCSC, is an Associate Professor at the University of Toronto and an attending urologits at the University Health Network, in Toronto, Canada.

Dr. Dean S. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2011. Dr. Elterman completed a two-year fellowship in Voiding Dysfunction, Neuro-Urology, Female Urology and Pelvic Reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City.

He completed his Masters degree in Clinical Epidemiology and Health Services Research at Weill Cornell Graduate School of Medical Sciences.

Dr. Elterman’s clinical and research interests include male health, voiding dysfunction and reconstruction including BPH, incontinence (male sling/artificial urinary sphincter), sexual dysfunction (penile prosthetic surgery); female voiding dysfunction including overactive bladder (sacral neuromodulation) and urinary incontinence.

He is the Medical Director of the Sexual Health Clinic at Princess Margaret Cancer Center and Fellowship Director for functional urology. He is the recipient of the 2022 SIU Innovators award, leads numerous clinical trials in BPH and neuromodulation, and has published over 190 peer reviewed manuscripts including the lead author of the Canadian guidelines for Male LUTS/BPH.

Disclosure information not submitted.

Presentation(s):

• Office-Based Therapies

  Friday, April 28, 2023
  12:40 PM – 1:20 PM CST

• 103HO - Surgical Management of Benign Prostatic Hypertrophy

  Friday, April 28, 2023
  2:00 PM – 5:00 PM CST

• Rezum Water Vapor Thermal Therapy and Emerging Nitinol Devices

  Saturday, April 29, 2023
  9:20 AM – 9:27 AM CST

• Round Table Discussion

  Saturday, April 29, 2023
  9:34 AM – 9:58 AM CST

• MP51-02: Aquablation Postoperative Bleeding Risk Reduction

  Sunday, April 30, 2023
  7:00 AM – 9:00 AM CST

• PD41-02: 12-Month Outcomes from the first North American study of the Zenflow Spring System for the Treatment of Benign Prostatic Hyperplasia (BPH)

  Monday, May 1, 2023
  7:10 AM – 7:20 AM CST

• Panel Discussions: Hot Topics in BPH - What I Need To Know

  Monday, May 1, 2023
  7:31 AM – 8:30 AM CST

• The UroLift System As A Catalyst For Optimizing BPH Care

  Monday, May 1, 2023
  10:15 AM – 10:35 AM CST

• MP76: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology IV

  Monday, May 1, 2023
  9:30 AM – 11:30 AM CST

• MP76-01: Mid-term Evaluation of Impact on Storage and Obstructive Symptoms with Rezūm: Outcomes of a Large, Multi-center, Prospective registry of Rezūm water vapor therapy benign prostatic enlargement

  Monday, May 1, 2023
  9:30 AM – 11:30 AM CST

• MP76-04: Prostate volume reduction by Rezum water vapour thermal therapy in glands <80cc and >80cc

  Monday, May 1, 2023
  9:30 AM – 11:30 AM CST

• MP76-08: Erectile and Ejaculatory Function after Rezum Water Vapour Thermal Therapy at 12- and 24-Months Follow-Up

  Monday, May 1, 2023
  9:30 AM – 11:30 AM CST

• Take Home Messages: BPH/LUTS

  Monday, May 1, 2023
  3:30 PM – 3:40 PM CST